HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Armin Ghobadi Selected Research

Hematopoietic Stem Cell Mobilization

10/2019A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Armin Ghobadi Research Topics

Disease

16Neoplasms (Cancer)
06/2022 - 01/2017
11B-Cell Lymphoma (Lymphoma, B Cell)
10/2022 - 12/2017
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 02/2014
7Lymphoma (Lymphomas)
10/2022 - 12/2016
6Multiple Myeloma
01/2022 - 05/2013
6Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 01/2019
5Cytokine Release Syndrome
10/2022 - 01/2017
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2022 - 12/2017
4Leukemia
01/2022 - 10/2016
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2021 - 01/2016
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 12/2016
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 12/2017
3Residual Neoplasm
01/2021 - 12/2019
3Graft vs Host Disease (Graft-Versus-Host Disease)
12/2020 - 06/2015
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2021 - 01/2017
2Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 06/2015
2Infections
12/2017 - 12/2016
1Carcinoma (Carcinomatosis)
01/2022
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1cell-associated neurotoxicity
01/2021
1Bites and Stings (Sting)
01/2021
1Leukocytosis (Pleocytosis)
01/2021
1Pancreatitis
01/2021
1Philadelphia Chromosome
01/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2021
1Inflammation (Inflammations)
10/2020
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2020
1Body Weight (Weight, Body)
12/2017
1Smoldering Multiple Myeloma
01/2017
1Pathologic Complete Response
12/2016
1Hodgkin Disease (Hodgkin's Disease)
12/2016
1Fever (Fevers)
12/2016
1Chromosome Aberrations (Chromosome Abnormalities)
11/2016

Drug/Important Bio-Agent (IBA)

13Chimeric Antigen ReceptorsIBA
10/2022 - 12/2017
12axicabtagene ciloleucelIBA
10/2022 - 01/2017
3Pharmaceutical PreparationsIBA
01/2022 - 01/2019
3Monoclonal AntibodiesIBA
01/2022 - 01/2019
3Cytarabine (Cytosar-U)FDA LinkGeneric
10/2020 - 12/2016
2Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2021
2AntigensIBA
01/2022 - 01/2021
2blinatumomabIBA
01/2021 - 12/2019
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021 - 10/2019
2Azacitidine (5 Azacytidine)FDA Link
01/2021 - 10/2016
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2020 - 12/2017
2Bendamustine HydrochlorideFDA Link
10/2020 - 05/2020
2tisagenlecleucelIBA
11/2019 - 01/2019
2Bortezomib (Velcade)FDA Link
10/2019 - 01/2019
2DecitabineFDA Link
12/2017 - 11/2016
1Glucose (Dextrose)FDA LinkGeneric
06/2022
1Alkylating AgentsIBA
01/2022
1HLA-A Antigens (HLA-A)IBA
01/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1CytokinesIBA
01/2022
1ALT-803IBA
01/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2021
1brexucabtagene autoleucelIBA
01/2021
1plerixaforFDA Link
01/2021
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
12/2020
1Calcineurin InhibitorsIBA
12/2020
1Methotrexate (Mexate)FDA LinkGeneric
12/2020
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
12/2020
1Rituximab (Mabthera)FDA Link
10/2020
1PENTAIBA
05/2020
1Prednisone (Sone)FDA LinkGeneric
05/2020
1selinexorIBA
01/2020
1CladribineFDA LinkGeneric
01/2020
1Filgrastim (Neupogen)FDA Link
01/2020
1ruxolitinibIBA
01/2020
11-dodecylpyridoxal (PLD)IBA
01/2019
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2019
1HLA-DPB1 antigen (HLA DPB1)IBA
01/2019
1AnthracyclinesIBA
01/2019
1carfilzomibIBA
01/2019
1liposomal doxorubicin (Doxil)FDA Link
01/2019
1alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA
01/2018
1fludarabineIBA
12/2017
1Etoposide (VP 16)FDA LinkGeneric
12/2016
1ElectrolytesIBA
12/2016
1Carmustine (FIVB)FDA Link
12/2016
1Propylene Glycol (1,2 Propanediol)FDA LinkGeneric
12/2016
1Melphalan (Alkeran)FDA LinkGeneric
12/2016
19-(4-fluoro-3-hydroxymethylbutyl)guanineIBA
06/2015
1Ganciclovir (Cytovene)FDA LinkGeneric
06/2015
1Phosphotransferases (Kinase)IBA
06/2015

Therapy/Procedure

21Therapeutics
01/2022 - 05/2013
8Stem Cell Transplantation
01/2022 - 06/2015
6Drug Therapy (Chemotherapy)
01/2022 - 01/2016
5Immunotherapy
01/2022 - 01/2019
4Cell Transplantation
01/2022 - 05/2013
4Transplantation
12/2020 - 01/2019
3Organ Transplantation
01/2021 - 01/2017
2Salvage Therapy
05/2020 - 12/2019
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2021
1Aftercare (After-Treatment)
01/2020
1Hematopoietic Stem Cell Mobilization
10/2019
1BEAM regimen
12/2016
1Homologous Transplantation
02/2014